Effects of activated complements on platelets

Acta Pharmacologica Sinica

Volumn 24, Issue 7, 2003, Pages 675-680+726

  Sa, Ya Lian ^a   Huang, Shou Jian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Blood platelets; Complement; Vascular endothelium; Vascular smooth muscle; Zymosan

Indexed keywords

BLOOD CLOTTING FACTOR 10A; CHROMOGENIC SUBSTRATE; COBROTOXIN; INDOMETACIN; TETRODOTOXIN; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CELL GROWTH; CELL VACUOLE; CHRONIC DISEASE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DNA CONTENT; DRUG EFFECT; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; GROWTH ACCELERATION; GROWTH INHIBITION; INFLAMMATION; MALE; METAMORPHOSIS; MITOCHONDRIAL RESPIRATION; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RAT; RIBOSOME; SMOOTH MUSCLE FIBER; SURFACE PROPERTY; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA; THROMBOCYTE SHAPE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VISCOSITY;

ANIMALS; AORTA, THORACIC; BLOOD PLATELETS; CATTLE; CELL DIVISION; CELLS, CULTURED; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; ENDOTHELIUM, VASCULAR; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; ZYMOSAN;

EID: 0038053193     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ren XD, Huang SJ, Sun JJ, Zhu ZG. Protective effect of cobra venom factor on pulmonary injury induced by oleic acid. Int J Immunopharmacol 1994; 16: 969-75.
2. Gui JS, Huang SJ. Cobra venom factor induces injury of cultured endothelial cells. Chin Pharmacol Bull 2000; 16: 635-8.
3. Ding, ZR, Huang SJ, Sun JJ. Induction of platelet activation by cobra venom factor from Naja naja atra in rat. Acta Pharmacol Sin 2000; 21: 649-54.
4. Wiedmer T, Esmon CT, Sims PJ. Complement proteins C5b-9 stimulate procoagulant activity through the platelets prothrombinase. Blood 1986; 68: 875-80.
5. Burger A, Wagner C, Hug F, Hansch GM. Up-regulation of intracellular calcium, cyclic adenosine monophosphate and fibronectin synthesis in tubuar epithelial cells by complement. Eur J Immunol 1999; 29: 1188-93.
6. Zucker MB, Grant RA. Aggregation and release reaction induced in human blood platelets by zymosan. J Immunol 1974; 112: 1219-30.
7. Xu Y, Ma M, Ippolito GC, Schroeder HW Jr, Carroll MC, Volanakis JE. Complement activation in factor D-difficient mice. Proc Natl Acad Sci 2001; 98: 14577-82.
8. Ren XD, Huang SJ, Wu CK, Sun JJ. An economical method for fractionation and purification of cobra venom factor from the venom of Naja naja atra. Chin J Pharmacol Toxicol 1994; 8: 271-5.
9. Vogel CW, Müller-Eberhard HJ. Cobra venom factor: improved method for purification and biochemical characterization. J Immunol Method 1984; 73: 203-20.
10. 2+-channels. Eur J Pharmacol 1998; 341: 343-7.
11. Kawai H, Yamamoto T, Hara H, Tamao Y. Inhibition of factor Xa-induced platelet aggregation by a selective thrombin inhibitor argatroban. Thromb Res 1994; 74: 185-91.
12. Shinitzky M, Barenholz Y. Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim Biophys Acta 1978; 515: 367-94.
13. Loveland, BE, Cooper DK, Sandrin MS. Are pigs transgenic for human complement regulatory proteins necessary for xenotransplantation? Transplantation 2000; 70: 567-8.
14. Dreja H, Annenkov A, Chernajovsky Y. Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis. Arthritis Rheum 2000; 43: 1698-709.
15. Asghar SS, Pasch MC. Therapeutic inhibition of the complement system. Y2K update. Front-Biosci 2000; 5E63-81.